Top

Published in:

29-06-2024 | Congenital Heart Anomaly

Advances in Diagnosis and Management of Fetal Heart Disease

Authors: Lindsay A. Edwards, Bhawna Arya

Published in: Current Pediatrics Reports | Issue 3/2024

Abstract

Purpose of Review

In this review, we will provide updates on the current state of diagnosis and management of fetal heart disease and highlight the research that is driving the field forward.

Recent Findings

The prenatal detection rate for congenital heart disease is increasing, but despite widespread prenatal anatomy screening, a significant proportion of congenital heart disease continues to go undetected before birth. Disparities drive lower detection rates in some population groups, such as the Hispanic population. For expectant parents who receive a prenatal diagnosis of congenital heart disease, psychological distress is common and can impact parent and child outcomes. New techniques, modalities, and therapies are emerging to aid in prenatal diagnosis, prognostication, and management of congenital heart disease and arrhythmias.

Summary

Prenatal diagnosis of heart disease and our options for in utero management are improving. The fetal cardiologist’s tool kit is expanding to include new and improved diagnostic and prognostic tools and therapy options.

Wu W, He J, Shao X. Incidence and mortality trend of congenital heart disease at the global, regional, and national level, 1990–2017. Medicine (Baltimore). 2020;99:e20593. https://doi.org/10.1097/MD.0000000000020593.CrossRefPubMed

Haxel CS, Johnson JN, Hintz S, Renno MS, Ruano R, Zyblewski SC, et al. Care of the fetus with congenital cardiovascular cisease: from diagnosis to delivery. Pediatrics. 2022;150:e2022056415C. https://doi.org/10.1542/peds.2022-056415C.CrossRefPubMed

van Velzen CL, Ket JCF, van de Ven PM, Blom NA, Haak MC. Systematic review and meta-analysis of the performance of second-trimester screening for prenatal detection of congenital heart defects. Int J Gynaecol Obstet. 2018;140:137–45. https://doi.org/10.1002/ijgo.12373.CrossRefPubMed

Barker PCA, Lewin MB, Donofrio MT, Altman CA, Ensing GJ, Arya B, et al. Specific considerations for pediatric, fetal, and congenital heart disease patients and echocardiography service providers during the 2019 novel coronavirus outbreak: Council on Pediatric and Congenital Heart Disease supplement to the statement of the American Society of Echocardiography: Endorsed by the Society of Pediatric Echocardiography and the Fetal Heart Society. J Am Soc Echocardiogr. 2020;33:658–65. https://doi.org/10.1016/j.echo.2020.04.005.CrossRefPubMedPubMedCentral

Altman CA, Donofrio MT, Arya B, Wasserman M, Ensing GJ, Cohen MS, et al. ASE statement on adapting pediatric, fetal, and congenital heart disease echocardiographic services to the evolving COVID-19 pandemic. J Am Soc Echocardiogr. 2021;34:553–61. https://doi.org/10.1016/j.echo.2021.01.012.CrossRefPubMedPubMedCentral

Nigam P, Weinberger S, Srivastava S, Lorber R. The evolution of fetal echocardiography before and during COVID-19. Prog Pediatr Cardiol. 2020;58:101259. https://doi.org/10.1016/j.ppedcard.2020.101259.CrossRefPubMedPubMedCentral

Schwartz BN, Klein JH, Barbosa MB, Hamersley SL, Hickey KW, Ahmadzia HK, et al. Expanding access to fetal telecardiology during the COVID-19 pandemic. Telemed J E Health. 2021;27:1235–40. https://doi.org/10.1089/tmj.2020.0508.CrossRefPubMed

Nigam P, Gramszlo C, Srivastava S, Sood E. Experiences of fetal care, social support, and emotional functioning during the COVID-19 pandemic in women carrying a fetus with CHD. Cardiol Young. 2023;1–7. https://doi.org/10.1017/S104795112300358X.

Kern-Goldberger AR, Sheils NE, Ventura MEM, Paderanga AJA, Janer CD, Donato PRB, et al. Patterns of prenatal care delivery and obstetric outcomes before and during the COVID-19 Pandemic. Am J Perinatol. 2023;40:582–8. https://doi.org/10.1055/a-1960-2682.CrossRefPubMed

10.

Boguslawski SM, Joseph NT, Stanhope KK, Ti AJ, Geary FH, Boulet SL. Impact of the COVID-19 pandemic on prenatal care utilization at a public hospital. Am J Perinatol. 2023;40:1484–94. https://doi.org/10.1055/a-1877-7951.CrossRefPubMed

11.

Arya B, Hammoud MS, Toth AJ, Woo J, Campbell M, Patel A, et al. Impact of United States COVID-19 regional changes on prenatal diagnosis and surgical outcomes of congenital heart disease: a Fetal Heart Society and Society of Thoracic Surgeons collaborative study. In: Proceedings of the American Association for Thoracic Surgery 104^th Annual Meeting; 2024 Apr 28; Toronto. Massachusetts: AATS; 2024. Available from: https://www.aats.org/resources/impact-of-united-states-covid-7056. Accessed 23 May 2004

12.

••Moon-Grady AJ, Donofrio MT, Gelehrter S, Hornberger L, Kreeger J, Lee W, et al. Guidelines and recommendations for performance of the fetal echocardiogram: an update from the American Society of Echocardiography. Journal of the American Society of Echocardiography. 2023:36:679–723. https://doi.org/10.1016/j.echo.2023.04.014. Most recent guidelines on when and how to perform fetal echo.

13.

Boehme C, Fruitman D, Eckersley L, Low R, Bennett J, McBrien A, et al. The diagnostic yield of fetal echocardiography indications in the current era. J Am Soc Echocardiogr. 2022;35:217-227.e1. https://doi.org/10.1016/j.echo.2021.09.005.CrossRefPubMed

14.

Cardinal M-P, Gagnon M-H, Têtu C, Beauchamp F-O, Roy L-O, Noël C, et al. Incremental detection of severe congenital heart disease by fetal echocardiography following a normal second trimester ultrasound scan in Québec. Canada Circ Cardiovasc Imaging. 2022;15:e013796. https://doi.org/10.1161/CIRCIMAGING.121.013796.CrossRefPubMed

15.

Bakker MK, Bergman JEH, Krikov S, Amar E, Cocchi G, Cragan J, et al. Prenatal diagnosis and prevalence of critical congenital heart defects: an international retrospective cohort study. BMJ Open. 2019;9:e028139. https://doi.org/10.1542/peds.2014-3783.CrossRefPubMedPubMedCentral

16.

•Quartermain MD, Pasquali SK, Hill KD, Goldberg DJ, Huhta JC, Jacobs JP, et al. Variation in prenatal diagnosis of congenital heart disease in infants. Pediatrics. 2015:136:e378–85. https://doi.org/10.1542/peds.2014-3783. Landmark paper describing variation in prenatal CHD diagnosis by lesion and geography.

17.

Krishnan A, Jacobs MB, Morris SA, Peyvandi S, Bhat AH, Chelliah A, et al. Impact of socioeconomic status, race and ethnicity, and geography on prenatal detection of hypoplastic left heart syndrome and transposition of the great arteries. Circulation. 2021;143:2049–60. https://doi.org/10.1161/CIRCULATIONAHA.120.053062.CrossRefPubMedPubMedCentral

18.

Davtyan A, Ostler H, Golding IF, Sun HY. Prenatal diagnosis rate of critical congenital heart disease remains inadequate with significant racial/ethnic and socioeconomic disparities and technical barriers. Pediatr Cardiol. 2023. https://doi.org/10.1007/s00246-023-03262-2.CrossRefPubMed

19.

Gianelle M, Turan S, Mech J, Chaves AH. The impact of neighborhood socioeconomic status, race and ethnicity, and language on prenatal diagnosis of CHD. Pediatr Cardiol. 2023;44:1168–75. https://doi.org/10.1007/s00246-023-03095-z.CrossRefPubMed

20.

Lopez KN, Baker-Smith C, Flores G, Gurvitz M, Karamlou T, Nunez Gallegos F, et al. Addressing social determinants of health and mitigating health disparities across the lifespan in congenital heart disease: a scientific statement from the American Heart Association. J Am Heart Assoc. 2022;11:e025358. https://doi.org/10.1161/JAHA.122.025358.CrossRefPubMedPubMedCentral

21.

Khoo NS, Van Essen P, Richardson M, Robertson T. Effectiveness of prenatal diagnosis of congenital heart defects in South Australia: a population analysis 1999–2003. Aust N Z J Obstet Gynaecol. 2008;48:559–63. https://doi.org/10.1111/j.1479-828X.2008.00915.x.CrossRefPubMed

22.

Stümpflen I, Stümpflen A, Wimmer M, Bernaschek G. Effect of detailed fetal echocardiography as part of routine prenatal ultrasonographic screening on detection of congenital heart disease. Lancet. 1996;348:854–7. https://doi.org/10.1016/S0140-6736(96)04069-X.CrossRefPubMed

23.

Meyer-Wittkopf M, Cooper S, Sholler G. Correlation between fetal cardiac diagnosis by obstetric and pediatric cardiologist sonographers and comparison with postnatal findings. Ultrasound Obstet Gynecol. 2001;17:392–7. https://doi.org/10.1046/j.1469-0705.2001.00381.x.CrossRefPubMed

24.

Pinto NM, Nelson R, Puchalski M, Metz TD, Smith KJ. Cost-effectiveness of prenatal screening strategies for congenital heart disease. Ultrasound Obstet Gynecol. 2014;44:50–7. https://doi.org/10.1002/uog.13287.CrossRefPubMedPubMedCentral

25.

Grandjean H, Larroque D, Levi S. The performance of routine ultrasonographic screening of pregnancies in the Eurofetus Study. Am J Obstet Gynecol. 1999;181:446–54. https://doi.org/10.1016/S0002-9378(99)70577-6.CrossRefPubMed

26.

Mangin-Heimos KS, Strube M, Taylor K, Galbraith K, O’Brien E, Rogers C, et al. Trajectories of maternal and paternal psychological distress after fetal diagnosis of moderate-severe congenital heart disease. J Pediatr Psychol. 2023;48:305–16. https://doi.org/10.1093/jpepsy/jsac067.CrossRefPubMed

27.

Salvador M, Vilaregut A, Moyano R, Ferrer Q, Gòmez O, Moratalla T, et al. Psychological distress, dyadic adjustment and family dynamics after prenatal diagnosis of congenital heart disease. An Pediatr (Engl Ed). 2022;97:179–89. https://doi.org/10.1016/j.anpede.2021.08.001.CrossRefPubMed

28.

Erbas GS, Herrmann-Lingen C, Ostermayer E, Kovacevic A, Oberhoffer-Fritz R, Ewert P, et al. Anxiety and depression levels in parents after counselling for fetal heart disease. J Clin Med. 2023;12:394. https://doi.org/10.3390/jcm12010394.CrossRefPubMedPubMedCentral

29.

Davey BT, Lee JH, Manchester A, Gunnlaugsson S, Ohannessian CM, Rodrigues R, et al. Maternal reaction and psychological coping after diagnosis of congenital heart disease. Matern Child Health J. 2023;27:671–9. https://doi.org/10.1007/s10995-023-03599-3.CrossRefPubMed

30.

Bratt E-L, Järvholm S, Ekman-Joelsson B-M, Johannsmeyer A, Carlsson S-Å, Mattsson L-Å, et al. Parental reactions, distress, and sense of coherence after prenatal versus postnatal diagnosis of complex congenital heart disease. Cardiol Young. 2019;29:1328–34. https://doi.org/10.1017/S1047951119001781.CrossRefPubMed

31.

Demianczyk AC, Bechtel Driscoll CF, Karpyn A, Shillingford A, Kazak AE, Sood E. Coping strategies used by mothers and fathers following diagnosis of congenital heart disease. Child Care Health Dev. 2022;48:129–38. https://doi.org/10.1111/cch.12913.CrossRefPubMed

32.

Wu Y, Kapse K, Jacobs M, Niforatos-Andescavage N, Donofrio MT, Krishnan A, et al. Association of maternal psychological distress with in utero brain development in fetuses with congenital heart disease. JAMA Pediatr. 2020;174:e195316. https://doi.org/10.1001/jamapediatrics.2019.5316.CrossRefPubMedPubMedCentral

33.

Ronai C, Katlaps I, Kim A, Valent AM, Thornburg KL, Madriago E. Perinatal stressors and consequences for neonates with critical congenital heart disease. J Cardiovasc Dev Dis. 2023;10:497. https://doi.org/10.3390/jcdd10120497.CrossRefPubMedPubMedCentral

34.

Tesson S, Butow PN, Marshall K, Fonagy P, Kasparian NA. Parent-child bonding and attachment during pregnancy and early childhood following congenital heart disease diagnosis. Health Psychol Rev. 2022;16:378–411. https://doi.org/10.1080/17437199.2021.1927136.CrossRefPubMed

35.

Harris KW, Brelsford KM, Kavanaugh-McHugh A, Clayton EW. Uncertainty of prenatally diagnosed congenital heart disease: a qualitative study. JAMA Netw Open. 2020;3:e204082. https://doi.org/10.1001/jamanetworkopen.2020.4082.CrossRefPubMedPubMedCentral

36.

Tacy TA, Kasparian NA, Karnik R, Geiger M, Sood E. Opportunities to enhance parental well-being during prenatal counseling for congenital heart disease. Semin Perinatol. 2022;46:151587. https://doi.org/10.1016/j.semperi.2022.151587.CrossRefPubMed

37.

Espinosa KM, Julian M, Wu Y, Lopez C, Donofrio MT, Krishnan A, et al. “The mental health piece is huge”: perspectives on developing a prenatal maternal psychological intervention for congenital heart disease. Cardiol Young. 2022;32:1268–75. https://doi.org/10.1017/S1047951121004030.CrossRefPubMed

38.

Sood E, Gramszlo C, Perez Ramirez A, Braley K, Butler SC, Davis JA, et al. Partnering with stakeholders to inform the co-design of a psychosocial intervention for prenatally diagnosed congenital heart disease. J Patient Exp. 2022;9:23743735221092490. https://doi.org/10.1177/23743735221092488.CrossRefPubMedPubMedCentral

39.

McKechnie AC, Elgersma KM, Ambrose MB, Sanchez Mejia AA, Shah KM, Iwaszko Wagner T, et al. Nurse-guided mobile health care program to reduce emotional distress experienced by parents of infants prenatally diagnosed with critical congenital heart disease: a pilot study. Prog Pediatr Cardiol. 2024;72:101687. https://doi.org/10.1016/j.ppedcard.2023.101687.CrossRefPubMed

40.

Hernandez-Andrade E, Benavides-Serralde JA, Cruz-Martinez R, Welsh A, Mancilla-Ramirez J. Evaluation of conventional Doppler fetal cardiac function parameters: E/A ratios, outflow tracts, and myocardial performance index. Fetal Diagn Ther. 2012;32:22–9. https://doi.org/10.1159/000330792.CrossRefPubMed

41.

Godfrey ME, Messing B, Cohen SM, Valsky DV, Yagel S. Functional assessment of the fetal heart: a review. Ultrasound Obstet Gynecol. 2012;39:131–44. https://doi.org/10.1002/uog.9064.CrossRefPubMed

42.

Bravo-Valenzuela NJ, Peixoto AB, Nardozza LM, Souza AS, Araujo Júnior E. Applicability and technical aspects of two-dimensional ultrasonography for assessment of fetal heart function. Med Ultrason. 2017;19:94–101. https://doi.org/10.11152/mu-934.CrossRefPubMed

43.

Huhta JC. Right ventricular function in the human fetus. J Perinat Med. 2001;29:381–9. https://doi.org/10.1515/JPM.2001.054.CrossRefPubMed

44.

•Falkensammer CB, Paul J, Huhta JC. Fetal congestive heart failure: Correlation of Tei-index and cardiovascular-score. J Perinat Med. 2001:29:390–8. https://doi.org/10.1515/JPM.2001.055. Landmark paper introducing cardiovascular profile score for grading fetal congestive heart failure.

45.

Hofstaetter C, Hansmann M, Eik-Nes SH, Huhta JC, Luther SL. A cardiovascular profile score in the surveillance of fetal hydrops. J Matern Fetal Neonatal Med. 2006;19:407–13. https://doi.org/10.1080/14767050600682446.CrossRefPubMed

46.

Mäkikallio K, Räsänen J, Mäkikallio T, Vuolteenaho O, Huhta JC. Human fetal cardiovascular profile score and neonatal outcome in intrauterine growth restriction. Ultrasound Obstet Gynecol. 2008;31:48–54. https://doi.org/10.1002/uog.5210.CrossRefPubMed

47.

Huhta JC. Fetal congestive heart failure. Semin Fetal Neonatal Med. 2005;10:542–52. https://doi.org/10.1016/j.siny.2005.08.005.CrossRefPubMed

48.

Tongsong T, Wanapirak C, Piyamongkol W, Sirichotiyakul S, Tongprasert F, Srisupundit K, et al. Fetal ventricular shortening fraction in hydrops fetalis. Obstet Gynecol. 2011;117:84–91. https://doi.org/10.1097/AOG.0b013e3181fc3887.CrossRefPubMed

49.

Barker PCA, Houle H, Li JS, Miller S, Herlong JR, Camitta MGW. Global longitudinal cardiac strain and strain rate for assessment of fetal cardiac function: novel experience with velocity vector imaging. Echocardiography. 2009;26:28–36. https://doi.org/10.1111/j.1540-8175.2008.00761.x.CrossRefPubMed

50.

••van Oostrum NHM, de Vet CM, Clur SB, van der Woude D a. A, van den Heuvel ER, Oei SG, et al. Fetal myocardial deformation measured with two-dimensional speckle-tracking echocardiography: longitudinal prospective cohort study of 124 healthy fetuses. Ultrasound Obstet Gynecol. 2022:59:651–9. https://doi.org/10.1002/uog.24781. Establishes reference ranges for fetal global longitudinal strain.

51.

Gezer C, Ekin A, Ozeren M, Taner CE, Mat E, Solmaz U. Can the myocardial performance index be used as a new predictive factor for a poor prognosis in fetuses with idiopathic polyhydramnios? J Ultrasound Med. 2016;35:2649–57. https://doi.org/10.7863/ultra.15.11086.CrossRefPubMed

52.

Szwast A, Tian Z, McCann M, Donaghue D, Rychik J. Right ventricular performance in the fetus with hypoplastic left heart syndrome. Ann Thorac Surg. 2009;87:1214–9. https://doi.org/10.1016/j.athoracsur.2008.11.032.CrossRefPubMed

53.

Ittleman B, Lowenstein S, Edwards LA, Caris E, Bhat A, Conwell J, et al. Fetal echocardiographic evaluation of tricuspid valve and right ventricular function including global longitudinal strain in hypoplastic left heart syndrome and association with postnatal outcomes. Pediatr Cardiol. 2024. https://doi.org/10.1007/s00246-024-03453-5.

54.

Gijtenbeek M, Eschbach SJ, Middeldorp JM, Klumper FJCM, Slaghekke F, Oepkes D, et al. Cardiac time intervals and myocardial performance index for prediction of twin-twin transfusion syndrome. Prenat Diagn. 2021;41:1498–503. https://doi.org/10.1002/pd.5981.CrossRefPubMedPubMedCentral

55.

Guasina F, Bellussi F, Morganelli G, Salsi G, Pilu G, Simonazzi G. Electronic spatiotemporal image correlation improves four-dimensional fetal echocardiography. Ultrasound Obstet Gynecol. 2018;51:357–60. https://doi.org/10.1002/uog.17474.CrossRefPubMed

56.

Pepes S, Parthenakis F, Makrigiannakis A, Germanakis I. Electronic versus conventional spatiotemporal image correlation (STIC) fetal echocardiography: a direct comparison. J Matern Fetal Neonatal Med. 2022;35:1310–7. https://doi.org/10.1080/14767058.2020.1752656.CrossRefPubMed

57.

Espinoza J, Lee W, Comstock C, Romero R, Yeo L, Rizzo G, et al. Collaborative study on 4-dimensional echocardiography for the diagnosis of fetal heart defects. J Ultrasound Med. 2010;29:1573–80. https://doi.org/10.7863/jum.2010.29.11.1573.CrossRefPubMed

58.

Inamura N, Taniguchi T, Yamada T, Tanaka T, Watanabe K, Kumagaya K, et al. The evaluation of fetal cardiac remote screening in the second trimester of pregnancy using the spatio-temporal image correlation method. Pediatr Cardiol. 2020;41:979–84. https://doi.org/10.1007/s00246-020-02346-7.CrossRefPubMed

59.

Yeo L, Romero R. Fetal intelligent navigation echocardiography (FINE): a novel method for rapid, simple, and automatic examination of the fetal heart. Ultrasound Obstet Gynecol. 2013;42:268–84. https://doi.org/10.1002/uog.12563.CrossRefPubMedPubMedCentral

60.

Yeo L, Romero R. Color and power Doppler combined with fetal intelligent navigation echocardiography (FINE) to evaluate the fetal heart. Ultrasound Obstet Gynecol. 2017;50:476–91. https://doi.org/10.1002/uog.17522.CrossRefPubMedPubMedCentral

61.

Yeo L, Luewan S, Romero R. Fetal intelligent navigation echocardiography (FINE) detects 98% of congenital heart disease. J Ultrasound Med. 2018;37:2577–93. https://doi.org/10.1002/jum.14616.CrossRefPubMedPubMedCentral

62.

Yeo L, Romero R. New and advanced features of fetal intelligent navigation echocardiography (FINE) or 5D heart. J Matern Fetal Neonatal Med. 2022;35:1498–516. https://doi.org/10.1080/14767058.2020.1759538.CrossRefPubMed

63.

Karmegaraj B, Kumar S, Srimurugan B, Sudhakar A, Simpson JM, Vaidyanathan B. 3D/4D spatiotemporal image correlation (STIC) fetal echocardiography provides incremental benefit over 2D fetal echocardiography in predicting postnatal surgical approach in double-outlet right ventricle. Ultrasound Obstet Gynecol. 2021;57:423–30. https://doi.org/10.1002/uog.21988.CrossRefPubMed

64.

Karapurkar S, Gurav A, Sudhakar A, Sasikumar N, Kumar RK, Vaidyanathan B. Three-dimensional/four-dimensional spatiotemporal image correlation morphology of the ductus arteriosus in fetuses with pulmonary atresia undergoing neonatal ductal stenting. Ann Pediatr Cardiol. 2023;16:233–41. https://doi.org/10.4103/apc.apc_95_23.CrossRefPubMed

65.

Pires G do V, Nieblas C de O, Bravo-Valenzuela NJ, Araujo Júnior E, Castro PT, Werner H. Ebstein anomaly: 3D virtual and physical models from obstetrical ultrasound data. Echocardiography. 2024:41:e15806https://doi.org/10.1111/echo.15806

66.

Huang J, Shi H, Chen Q, Hu J, Zhang Y, Song H, et al. Three-dimensional printed model fabrication and effectiveness evaluation in fetuses with congenital heart disease or with a normal heart. J Ultrasound Med. 2021;40:15–28. https://doi.org/10.1002/jum.15366.CrossRefPubMed

67.

••Udine M, Loke Y-H, Goudar S, Donofrio MT, Truong U, Krishnan A. The current state and potential innovation of fetal cardiac MRI. Front Pediatr. 2023:11:1219091. https://doi.org/10.3389/fped.2023.1219091. Well-written review on fetal cardiac MRI.

68.

van Amerom JF, Goolaub DS, Schrauben EM, Sun L, Macgowan CK, Seed M. Fetal cardiovascular blood flow MRI: techniques and applications. Br J Radiol. 2023;96:20211096. https://doi.org/10.1259/bjr.20211096.CrossRefPubMed

69.

Tavares de Sousa M, Hecher K, Yamamura J, Kording F, Ruprecht C, Fehrs K, et al. Dynamic fetal cardiac magnetic resonance imaging in four-chamber view using Doppler ultrasound gating in normal fetal heart and in congenital heart disease: comparison with fetal echocardiography. Ultrasound Obstet Gynecol. 2019;53:669–75. https://doi.org/10.1002/uog.20167.CrossRefPubMed

70.

Kording F, Yamamura J, de Sousa MT, Ruprecht C, Hedström E, Aletras AH, et al. Dynamic fetal cardiovascular magnetic resonance imaging using Doppler ultrasound gating. J Cardiovasc Magn Reson. 2018;20:17. https://doi.org/10.1186/s12968-018-0440-4.CrossRefPubMedPubMedCentral

71.

Lloyd DFA, van Amerom JFP, Pushparajah K, Simpson JM, Zidere V, Miller O, et al. An exploration of the potential utility of fetal cardiovascular MRI as an adjunct to fetal echocardiography. Prenat Diagn. 2016;36:916–25. https://doi.org/10.1002/pd.4912.CrossRefPubMedPubMedCentral

72.

Roy CW, van Amerom JFP, Marini D, Seed M, Macgowan CK. Fetal cardiac MRI: a review of technical advancements. Top Magn Reson Imaging. 2019;28:235–44. https://doi.org/10.1097/RMR.0000000000000218.CrossRefPubMedPubMedCentral

73.

Lloyd DFA, Pushparajah K, Simpson JM, van Amerom JFP, van Poppel MPM, Schulz A, et al. Three-dimensional visualisation of the fetal heart using prenatal MRI with motion-corrected slice-volume registration: a prospective, single-centre cohort study. Lancet. 2019;393:1619–27. https://doi.org/10.1016/S0140-6736(18)32490-5.CrossRefPubMedPubMedCentral

74.

Lloyd DFA, van Poppel MPM, Pushparajah K, Vigneswaran TV, Zidere V, Steinweg J, et al. Analysis of 3-dimensional arch anatomy, vascular flow, and postnatal outcome in cases of suspected coarctation of the aorta using fetal cardiac magnetic resonance imaging. Circ Cardiovasc Imaging. 2021;14:e012411. https://doi.org/10.1161/CIRCIMAGING.121.012411.CrossRefPubMedPubMedCentral

75.

Sun L, van Amerom JFP, Marini D, Portnoy S, Lee F-T, Saini BS, et al. MRI characterization of hemodynamic patterns of human fetuses with cyanotic congenital heart disease. Ultrasound Obstet Gynecol. 2021;58:824–36. https://doi.org/10.1002/uog.23707.10.1002/uog.23707.CrossRefPubMed

76.

Seidl-Mlczoch E, Kasprian G, Ba-Ssalamah A, Stuempflen M, Kitzmueller E, Muin DA, et al. Characterization of phenotypic spectrum of fetal heterotaxy syndrome by combining ultrasound and magnetic resonance imaging. Ultrasound Obstet Gynecol. 2021;58:837–45. https://doi.org/10.1002/uog.23705.CrossRefPubMedPubMedCentral

77.

Serrano RM, Hussain S, Brown B, Ebenroth ES, Farrell A. Risk stratification of patients with hypoplastic left heart syndrome and intact atrial septum using fetal MRI and echocardiography. Cardiol Young. 2020;30:790–8. https://doi.org/10.1017/S1047951120001006.CrossRefPubMed

78.

Chelliah A, Berger JT, Blask A, Donofrio MT. Clinical utility of fetal magnetic resonance imaging in tetralogy of Fallot with absent pulmonary valve. Circulation. 2013;127:757–9. https://doi.org/10.1161/CIRCULATIONAHA.112.139758.CrossRefPubMed

79.

Sadhwani A, Wypij D, Rofeberg V, Gholipour A, Mittleman M, Rohde J, et al. Fetal brain volume predicts neurodevelopment in congenital heart disease. Circulation. 2022;145:1108–19. https://doi.org/10.1161/CIRCULATIONAHA.121.056305.CrossRefPubMedPubMedCentral

80.

••Arnaout R, Curran L, Zhao Y, Levine JC, Chinn E, Moon-Grady AJ. An ensemble of neural networks provides expert-level prenatal detection of complex congenital heart disease. Nat Med. 2021:27:882–91. https://doi.org/10.1038/s41591-021-01342-5. Groundbreaking research in machine learning-driven fetal CHD detection.

81.

Gong Y, Zhang Y, Zhu H, Lv J, Cheng Q, Zhang H, et al. Fetal congenital heart disease echocardiogram screening based on DGACNN: adversarial one-class classification combined with video transfer learning. IEEE Trans Med Imaging. 2020;39:1206–22. https://doi.org/10.1109/TMI.2019.2946059.CrossRefPubMed

82.

Nurmaini S, Partan RU, Bernolian N, Sapitri AI, Tutuko B, Rachmatullah MN, et al. Deep learning for improving the effectiveness of routine prenatal screening for major congenital heart diseases. J Clin Med. 2022;11:6454. https://doi.org/10.3390/jcm11216454.CrossRefPubMedPubMedCentral

83.

Tang J, Liang Y, Jiang Y, Liu J, Zhang R, Huang D, et al. A multicenter study on two-stage transfer learning model for duct-dependent CHDs screening in fetal echocardiography. npj Digit Med. 2023:6:1–10. https://doi.org/10.1038/s41746-023-00883-y.

84.

Day TG, Budd S, Tan J, Matthew J, Skelton E, Jowett V, et al. Prenatal diagnosis of hypoplastic left heart syndrome on ultrasound using artificial intelligence: How does performance compare to a current screening programme? Prenat Diagn. 2023; 1–8. https://doi.org/10.1002/pd.6445.

85.

Rasanen J, Wood DC, Debbs RH, Cohen J, Weiner S, Huhta JC. Reactivity of the human fetal pulmonary circulation to maternal hyperoxygenation increases during the second half of pregnancy: a randomized study. Circulation. 1998;97:257–62. https://doi.org/10.1161/01.cir.97.3.257.CrossRefPubMed

86.

Szwast A, Tian Z, McCann M, Donaghue D, Rychik J. Vasoreactive response to maternal hyperoxygenation in the fetus with hypoplastic left heart syndrome. Circ Cardiovasc Imaging. 2010;3:172–8. https://doi.org/10.1161/CIRCIMAGING.109.848432.CrossRefPubMed

87.

Mardy C, Kaplinski M, Peng L, Blumenfeld YJ, Kwiatkowski DM, Tacy TA, et al. Maternal hyperoxygenation testing in fetuses with hypoplastic left-heart syndrome: association with postnatal atrial septal restriction. Fetal Diagn Ther. 2021;48:678–89. https://doi.org/10.1159/000519322.CrossRefPubMed

88.

Cox KL, Morris SA, Tacy T, Long J, Becker J, Schoppe L, et al. Impact of maternal hyperoxygenation on myocardial deformation and loading conditions in fetuses with and without left heart hypoplasia. J Am Soc Echocardiogr. 2022;35:773-781.e4. https://doi.org/10.1016/j.echo.2022.03.015.CrossRefPubMed

89.

Schidlow DN, Donofrio MT. Prenatal maternal hyperoxygenation testing and implications for critical care delivery planning among fetuses with congenital heart disease: early experience. Am J Perinatol. 2018;35:16–23. https://doi.org/10.1055/s-0037-1603991.CrossRefPubMed

90.

Szwast A, Penney C, Sharma P, Rychik J. Role of maternal hyperoxygenation testing to predict need for balloon atrial septostomy in fetal d-transposition of great arteries. Ultrasound Obstet Gynecol. 2024. https://doi.org/10.1002/uog.27664.

91.

Lara DA, Morris SA, Maskatia SA, Challman M, Nguyen M, Feagin DK, et al. Pilot study of chronic maternal hyperoxygenation and effect on aortic and mitral valve annular dimensions in fetuses with left heart hypoplasia. Ultrasound Obstet Gynecol. 2016;48:365–72. https://doi.org/10.1002/uog.15846.CrossRefPubMed

92.

Edwards LA, Lara DA, Sanz Cortes M, Hunter JV, Andreas S, Nguyen MJ, et al. Chronic maternal hyperoxygenation and effect on cerebral and placental vasoregulation and neurodevelopment in fetuses with left heart hypoplasia. Fetal Diagn Ther. 2019;46:45–57. https://doi.org/10.1159/000489123.CrossRefPubMed

93.

••Strasburger JF, Eckstein G, Butler M, Noffke P, Wacker-Gussmann A. Fetal arrhythmia diagnosis and pharmacologic management. J Clin Pharmacol. 2022:62 Suppl 1:S53–66. https://doi.org/10.1002/jcph.2129. Excellent review on diagnosis and management of fetal arrhythmias.

94.

Zhang L, Huang H, Yang S, Yin H, Chen D, Lu L. An intravenous immunoglobulin scheme successfully preventing recurrent CHB in fetuses of Anti-SSA/SSB-positive mothers. JACC Clin Electrophysiol. 2023;9:1002–3. https://doi.org/10.1016/j.jacep.2022.12.014.CrossRefPubMed

95.

Saxena A, Izmirly PM, Mendez B, Buyon JP, Friedman DM. Prevention and treatment in utero of autoimmune-associated congenital heart block. Cardiol Rev. 2014;22(06):263–7. https://doi.org/10.1097/CRD.0000000000000026.CrossRefPubMedPubMedCentral

96.

Cuneo BF, Sonesson S-E, Levasseur S, Moon-Grady AJ, Krishnan A, Donofrio MT, et al. Home monitoring for Fetal Heart Rhythm During Anti-Ro Pregnancies. J Am Coll Cardiol. 2018;72:1940–51. https://doi.org/10.1016/j.jacc.2018.07.076.CrossRefPubMed

97.

Sunderji S, Peyvandi S, Jaeggi E, Szwast A, Ryan G, Tessier F, et al. NAFTNet retrospective report on the treatment of anti-Ro/SSA mediated fetal heart block with dexamethasone. J Matern Fetal Neonatal Med. 2022;35:9263–70. https://doi.org/10.1080/14767058.2022.2025536.CrossRefPubMed

98.

Society for Maternal-Fetal Medicine (SMFM), Silver R, Craigo S, Porter F, Osmundson SS, Kuller JA, et al. Society for Maternal-Fetal Medicine Consult Series #64: Systemic lupus erythematosus in pregnancy. Am J Obstet Gynecol. 2023:228:B41–60. https://doi.org/10.1016/j.ajog.2022.09.001.

99.

Cuneo BF, Buyon JP, Sammaritano L, Jaeggi E, Arya B, Behrendt N, et al. Knowledge is power: regarding SMFM Consult Series #64: Systemic lupus erythematosus in pregnancy. Am J Obstet Gynecol. 2023;229:361–3. https://doi.org/10.1016/j.ajog.2023.06.040.CrossRefPubMed

100.

Buyon JP, Masson M, Izmirly CG, Phoon C, Acherman R, Sinkovskaya E, et al. Prospective evaluation of high titer autoantibodies and fetal home monitoring in the detection of atrioventricular block among anti-SSA/Ro pregnancies. Arthritis Rheumatol. 2024;76:411–20. https://doi.org/10.1002/art.42733.CrossRefPubMed

101.

Freud LR, Wilkins-Haug LE, Beroukhim RS, LaFranchi T, Phoon CK, Glickstein JS, et al. Effect of in utero non-steroidal anti-inflammatory drug therapy for severe Ebstein anomaly or tricuspid valve dysplasia (NSAID therapy for fetal Ebstein anomaly). Am J Cardiol. 2021;141:106–12. https://doi.org/10.1016/j.amjcard.2020.11.013.CrossRefPubMed

102.

Vorisek CN, Zurakowski D, Tamayo A, Axt-Fliedner R, Siepmann T, Friehs I. Postnatal circulation in patients with aortic stenosis undergoing fetal aortic valvuloplasty: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2022;59:576–84. https://doi.org/10.1002/uog.24807.CrossRefPubMed

103.

Hogan WJ, Grinenco S, Armstrong A, Devlieger R, Dangel J, Ferrer Q, et al. Fetal cardiac intervention for pulmonary atresia with intact ventricular septum: International Fetal Cardiac Intervention Registry. Fetal Diagn Ther. 2020;47:731–9. https://doi.org/10.1159/000508045.CrossRef

104.

Tulzer A, Arzt W, Scharnreitner I, Hochpoechler J, Bauer C, Tulzer G. Complications associated with fetal cardiac interventions: prevalence and management - experience from 213 procedures. Fetal Diagn Ther. 2023;49:434–42. https://doi.org/10.1159/000527121.CrossRef

105.

AIUM practice parameter for the performance of fetal echocardiography. J Ultrasound Med. 2020:39:E5–16. https://doi.org/10.1002/jum.15188.

106.

Donofrio MT, Moon-Grady AJ, Hornberger LK, Copel JA, Sklansky MS, Abuhamad A, et al. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association. Circulation. 2014;129:2183–242. https://doi.org/10.1161/01.cir.0000437597.44550.5d.CrossRefPubMed

Title: Advances in Diagnosis and Management of Fetal Heart Disease
Authors: Lindsay A. Edwards
Bhawna Arya
Publication date: 29-06-2024
Publisher: Springer US
Keywords: Congenital Heart Anomaly
Prenatal and Perinatal Diagnostics
Pediatric Cardiology
Cardiac Arrhythmia
Echocardiography
Fetal Magnetic Resonance Imaging
Pregnancy
Congenital Heart Anomaly
Cardiac Arrhythmia
Echocardiography
Published in: Current Pediatrics Reports / Issue 3/2024
Electronic ISSN: 2167-4841
DOI: https://doi.org/10.1007/s40124-024-00319-5

Pediatric Environmental Health In Brazil and Latin America: An Appraisal and Future Perspectives

Climate Change and Heat: Challenges for Child Health Outcomes and Inequities

Anomalous Aortic Origin of a Coronary Artery in Pediatric Patients

Open Access

Lipid abnormalities in youth

Dyslipidemia
Review

Impact of the Relational, Built, Community, and Policy/Political Environments on Immigrant Child Health: A Narrative Review

Open Access

The Impact of the COVID-19 Pandemic on Adolescent Substance Use

Keynote series | Spotlight on menopause

Menopause
Video Series

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.

Prof. Martha Hickey

Dr. Claudia Barth

Dr. Samar El Khoudary

Developed by: Springer Medicine

Watch now

A quick guide to ECGs

Electrocardiography
Training Course

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date.

PD Dr. Carsten W. Israel

Developed by: Springer Medizin

Start the cases

Navigating neuroimaging in Alzheimer disease care

Springer Medicine

Advances in Diagnosis and Management of Fetal Heart Disease

Abstract

Purpose of Review

Recent Findings

Summary

Other articles of this Issue 3/2024

Pediatric Environmental Health In Brazil and Latin America: An Appraisal and Future Perspectives

Climate Change and Heat: Challenges for Child Health Outcomes and Inequities

Anomalous Aortic Origin of a Coronary Artery in Pediatric Patients

Lipid abnormalities in youth

Impact of the Relational, Built, Community, and Policy/Political Environments on Immigrant Child Health: A Narrative Review

The Impact of the COVID-19 Pandemic on Adolescent Substance Use

Keynote series | Spotlight on menopause

A quick guide to ECGs

Navigating neuroimaging in Alzheimer disease care

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content